Bicara Therapeutics Inc. 10-Q filing
Filed 2026-05-11 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001628280-26-033429
- Form type
- 10-Q
- CIK
- 0002023658
- Primary document
- https://www.sec.gov/Archives/edgar/data/2023658/000162828026033429/bcax-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Bicara Therapeutics Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-60.2M | - | - |
| Net Income | $-56.2M | - | - |
| Eps Basic | -0.93 | - | - |
| Eps Diluted | -0.93 | - | - |
| Cash And Equivalents | $323.5M | - | - |
| Total Assets | $553.6M | - | - |
| Total Liabilities | $39.6M | - | - |
| Shareholders Equity | $514.0M | - | - |
| Operating Cash Flow | $-37.5M | - | - |
| Capital Expenditures | $60,000 | - | - |